Ticker LaunchIPO · FREQ
Korro Bio, Inc.
Formerly Frequency Therapeutics, Inc.
Korro Bio, Inc. (FREQ) priced its initial public offering on Oct 4, 2019 at $14.00 per share, within its $14.00–$16.00 range, raising $84M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $426.4M. Simpson Thacher advised the underwriters.
- Status
- IPO
- Ticker
- FREQ
- Exchange
- Nasdaq Global Select
- Priced
- Oct 4, 2019
- IPO price
- $14.00
- Price range
- $14.00–$16.00
- Raised
- $84M
- Market cap at IPO price
- $426.4M
- First filed
- Sep 6, 2019
- Underwriters' counsel
- Simpson Thacher
- Sector
- Biotech & pharma
- Country / state
- MA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Sep 6, 2019
- Latest amendment Sep 23, 2019
- Final prospectus (424B4) Oct 4, 2019
- All filings on EDGAR CIK 1703647
Other Biotech & pharma IPOs in 2019
- Innate Pharma SAIPHA · Oct 18, 2019
- BioNTech SEBNTX · Oct 11, 2019 · $150M
- Vir Biotechnology, Inc.VIR · Oct 11, 2019 · $142.9M
- Aprea Therapeutics, Inc.APRE · Oct 4, 2019 · $85M
- Viela Bio, Inc.VIE · Oct 4, 2019 · $150.1M
- IGM Biosciences, Inc.IGMS · Sep 18, 2019 · $175M